Visceral Fat Area and Subcutaneous Fat Area Increase in Hyperthyroidism Patients After Treatment—A Single-Group Repeated-Measures Trial

References

• Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023;11(4):282–298. doi:10.1016/S2213-8587(23)00005-0
   PubMed Web of Science ®Google Scholar
• Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. doi:10.1089/thy.2016.0229
   PubMed Web of Science ®Google Scholar
• Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39–55. doi:10.1038/nrcardio.2016.174
   PubMed Web of Science ®Google Scholar
• Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–509. doi:10.1056/NEJM200102153440707
   PubMed Web of Science ®Google Scholar
• Nyirenda MJ, Clark DN, Finlayson AR, et al. Thyroid disease and increased cardiovascular risk. Thyroid. 2005;15(7):718–724. doi:10.1089/thy.2005.15.718
   PubMed Web of Science ®Google Scholar
• Brandt F, Thvilum M, Almind D, et al. Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS One. 2013;8(6):e66711. doi:10.1371/journal.pone.0066711
   PubMed Web of Science ®Google Scholar
• Ryödi E, Salmi J, Jaatinen P, et al. Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - a nation-wide cohort study with a long-term follow-up. Clin Endocrinol. 2014;80(5):743–750. doi:10.1111/cen.12359
   PubMed Web of Science ®Google Scholar
• Metso S, Auvinen A, Salmi J, Huhtala H, Jaatinen P. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol. 2008;68(3):450–457. doi:10.1111/j.1365-2265.2007.03064.x
   PubMed Web of Science ®Google Scholar
• Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 1998;338(11):712–718. doi:10.1056/NEJM199803123381103
   PubMed Web of Science ®Google Scholar
• Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA. 2005;294(1):71–80. doi:10.1001/jama.294.1.71
   PubMed Web of Science ®Google Scholar
• Hall P, Lundell G, Holm LE. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol. 1993;128(3):230–234. doi:10.1530/acta.0.1280230
   PubMedGoogle Scholar
• Lönn L, Stenlöf K, Ottosson M, Lindroos AK, Nyström E, Sjöström L. Body weight and body composition changes after treatment of hyperthyroidism. J Clin Endocrinol Metab. 1998;83(12):4269–4273. doi:10.1210/jcem.83.12.5338
   PubMed Web of Science ®Google Scholar
• Ito A, Ando T, Nozaki A, Haraguchi A, Horie I, Kawakami A. VISCERAL AND SUBCUTANEOUS FAT INCREASED AFTER TREATMENT OF GRAVES DISEASE. Endocr Pract. 2020;26(5):484–491. doi:10.4158/EP-2019-0459
   PubMed Web of Science ®Google Scholar
• Steinhoff KG, Krause K, Linder N, et al. Effects of Hyperthyroidism on Adipose Tissue Activity and Distribution in Adults. Thyroid. 2021;31(3):519–527. doi:10.1089/thy.2019.0806
   PubMed Web of Science ®Google Scholar
• Huang H, Zheng X, Wen X, Zhong J, Zhou Y, Xu L. Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes. Front Endocrinol. 2023;14:1144834. doi:10.3389/fendo.2023.1144834
   PubMed Web of Science ®Google Scholar
• Zhang B, He J, Guo P, et al. Ratio of visceral fat area to body fat mass (VBR) is a superior predictor of coronary heart disease. Chin Med J. 2023;1:3.
   Google Scholar
• Paiman EHM, de Mutsert R, Widya RL, Rosendaal FR, Jukema JW, Lamb HJ. The role of insulin resistance in the relation of visceral, abdominal subcutaneous and total body fat to cardiovascular function. Nutr Metab Cardiovasc Dis. 2020;30(12):2230–2241. doi:10.1016/j.numecd.2020.07.011
   PubMed Web of Science ®Google Scholar
• Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity. 2010;18(11):2191–2198. doi:10.1038/oby.2010.59
   PubMed Web of Science ®Google Scholar
• Bartalena L. Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol. 2013;9(12):724–734. doi:10.1038/nrendo.2013.193
   PubMed Web of Science ®Google Scholar
• Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–922. doi:10.2337/dc09-1825
   PubMed Web of Science ®Google Scholar
• Andreoli A, Scalzo G, Masala S, Tarantino U, Guglielmi G. Body composition assessment by dual-energy X-ray absorptiometry (DXA). Radiol Med. 2009;114(2):286–300. doi:10.1007/s11547-009-0369-7
   PubMed Web of Science ®Google Scholar
• Polak J, Moro C, Klimcakova E, et al. The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients. Am J Physiol Endocrinol Metab. 2007;293(1):E246–E251. doi:10.1152/ajpendo.00688.2006
   PubMed Web of Science ®Google Scholar
• Hellström L, Wahrenberg H, Reynisdottir S, Arner P. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab. 1997;82(1):159–166. doi:10.1210/jcem.82.1.3664
   PubMed Web of Science ®Google Scholar
• Martínez-Sánchez N, Moreno-Navarrete JM, Contreras C, et al. Thyroid hormones induce browning of white fat. J Endocrinol. 2017;232(2):351–362. doi:10.1530/JOE-16-0425
   PubMed Web of Science ®Google Scholar
• Seale P, Kajimura S, Spiegelman BM. Transcriptional control of brown adipocyte development and physiological function--of mice and men. Genes Dev. 2009;23(7):788–797. doi:10.1101/gad.1779209
   PubMed Web of Science ®Google Scholar
• Yau WW, Yen PM. Thermogenesis in adipose tissue activated by thyroid hormone. Int J Mol Sci. 2020;21(8):3020. doi:10.3390/ijms21083020
   PubMed Web of Science ®Google Scholar
• Adams AC, Astapova I, Fisher FM, et al. Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner. J Biol Chem. 2010;285(19):14078–14082. doi:10.1074/jbc.C110.107375
   PubMed Web of Science ®Google Scholar
• Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators--a critical appraisal. Cell Metab. 2012;16(6):693–705. doi:10.1016/j.cmet.2012.11.001
   PubMed Web of Science ®Google Scholar
• Bande AR, Kalra P, Dharmalingam M, Selvan C, Suryanarayana KM. Serum fibroblast growth factor 21 levels in patients with hyperthyroidism and its association with body fat percentage. Indian J Endocrinol Metab. 2019;23(5):557–562. doi:10.4103/ijem.IJEM_273_19
   PubMedGoogle Scholar
• Kobayashi H, Nakamura T, Miyaoka K, et al. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J. 2001;65(3):193–199. doi:10.1253/jcj.65.193
   PubMedGoogle Scholar
• Luo Y, Ma X, Shen Y, et al. Positive relationship between serum low-density lipoprotein cholesterol levels and visceral fat in a Chinese nondiabetic population. PLoS One. 2014;9(11):e112715. doi:10.1371/journal.pone.0112715
   PubMed Web of Science ®Google Scholar
• Raghu Teja K, Durgaprasad BK, Vijayalakshmi P. Evaluation and comparative correlation of abdominal fat related parameters in obese and non-obese groups using computed tomography. Curr Med Imaging. 2021;17(3):417–424. doi:10.2174/1573405616666201008145801
   PubMed Web of Science ®Google Scholar
• Lemieux S, Prud’homme D, Moorjani S, et al. Do elevated levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concentrations in men? Atherosclerosis. 1995;118(1):155–164. doi:10.1016/0021-9150(95)05603-T
   PubMed Web of Science ®Google Scholar
• Pelletier-Beaumont E, Arsenault BJ, Alméras N, et al. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men. Atherosclerosis. 2012;221(2):577–582. doi:10.1016/j.atherosclerosis.2012.01.023
   PubMed Web of Science ®Google Scholar
• Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord. 2004;28(8):1018–1025. doi:10.1038/sj.ijo.0802695
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/CIRCULATIONAHA.106.675355
   PubMed Web of Science ®Google Scholar
• Song SO, Hwang YC, Ryu HU, et al. Lower high-density lipoprotein cholesterol concentration is independently associated with greater future accumulation of intra-abdominal fat. Endocrinol Metab. 2021;36(4):835–844. doi:10.3803/EnM.2021.1130
   Google Scholar
• Park H-R, Shin S-R, Han AL, Jeong YJ. The correlation between the triglyceride to high density lipoprotein cholesterol ratio and computed tomography-measured visceral fat and cardiovascular disease risk factors in local adult male subjects. Korean J Fam Med. 2015;36(6). doi:10.4082/kjfm.2015.36.6.335
   Google Scholar
• Bakker O, Hudig F, Meijssen S, Wiersinga WM. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun. 1998;249(2):517–521.
   PubMed Web of Science ®Google Scholar
• Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J Biol Chem. 2003;278(36):34114–34118. doi:10.1074/jbc.M305417200
   PubMed Web of Science ®Google Scholar
• Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–293. doi:10.1089/10507250252949405
   PubMed Web of Science ®Google Scholar
• Faure P, Oziol L, Artur Y, Chomard P. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms. Biochimie. 2004;86(6):411–418. doi:10.1016/j.biochi.2004.04.009
   PubMed Web of Science ®Google Scholar
• Gullberg H, Rudling M, Forrest D, Angelin B, Vennström B. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol Endocrinol. 2000;14(11):1739–1749. doi:10.1210/mend.14.11.0548
   PubMedGoogle Scholar
• Nikkilä EA, Kekki M. Plasma triglyceride metabolism in thyroid disease. J Clin Invest. 1972;51(8):2103–2114. doi:10.1172/JCI107017
   PubMed Web of Science ®Google Scholar
• Agdeppa D, Macaron C, Mallik T, Schnuda ND. Plasma high density lipoprotein cholesterol in thyroid disease. J Clin Endocrinol Metab. 1979;49(5):726–729. doi:10.1210/jcem-49-5-726
   PubMed Web of Science ®Google Scholar
• Aviram M, Luboshitzky R, Brook JG. Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem. 1982;15(1):62–66. doi:10.1016/S0009-9120(82)90529-X
   PubMed Web of Science ®Google Scholar
• Lithell H, Boberg J, Hellsing K, et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest. 1981;11(1):3–10. doi:10.1111/j.1365-2362.1981.tb01758.x
   PubMed Web of Science ®Google Scholar
• Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community diabetes study. Diabetes Care. 1999;22(11):1808–1812. doi:10.2337/diacare.22.11.1808
   PubMed Web of Science ®Google Scholar
• Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52(1):172–179. doi:10.2337/diabetes.52.1.172
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–1649. doi:10.1016/S0140-6736(05)67663-5
   PubMed Web of Science ®Google Scholar
• Jellinger PS, Handelsman Y, Rosenblit PD, et al. American association of clinical endocrinologists and American college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23(Suppl 2):2.
   Google Scholar